Industries de la santé
Bone Therapeutics’ pivotal phase III osteonecrosis trial with PREOB® hits a new milestone : 30 centres across Europe now active
12 Novembre 2013
Gosselies, Belgium, 7th November 2013 - BONE THERAPEUTICS, the regenerative therapy company addressing unmet needs in the field of orthopaedics via a minimally invasive approach, announces today that its phase III pivotal trial to treat osteonecrosis with its lead bone forming cell product PREOB® is actively running in 30 European centres. |Bone Therapeutics obtained clearance from the...